← back to search

Shu-Feng Zhou

Huaqiao University · CN
Area of research
Pharmacology · Biochemistry
Research interest
Research interests include Pharmacogenetics and Drug Metabolism, Eicosanoids and Hypertension Pharmacology, Drug Transport and Resistance Mechanisms, and Microtubule and mitosis dynamics.
h-index
37
citations
4,221
works
69
NIH funding
primary concept
email

Recent publications

Soluble (pro)renin receptor via β-catenin enhances urine concentration capability as a target of liver X receptor
Proceedings of the National Academy of Sciences 2016cited by 100position: middledoi
Collecting duct (pro)renin receptor targets ENaC to mediate angiotensin II-induced hypertension
American Journal of Physiology-Renal Physiology 2016cited by 75position: middledoi
Inhibition of Aurora kinases induces apoptosis and autophagy via AURKB/p70S6K/RPL15 axis in human leukemia cells
Cancer Letters 2016cited by 48position: lastdoi
Computational Identification of the Paralogs and Orthologs of Human Cytochrome P450 Superfamily and the Implication in Drug Discovery
International Journal of Molecular Sciences 2016cited by 33position: lastdoi
Renal medullary (pro)renin receptor contributes to angiotensin II-induced hypertension in rats via activation of the local renin–angiotensin system
BMC Medicine 2015cited by 77position: middledoi
Clinical Association Between Pharmacogenomics and Adverse Drug Reactions
Drugs 2015cited by 73position: lastdoi
Graphene quantum dots induce apoptosis, autophagy, and inflammatory response via p38 mitogen-activated protein kinase and nuclear factor-κB mediated signaling pathways in activated THP-1 macrophages
Toxicology 2014cited by 197position: lastdoi
Prostaglandin E-Prostanoid <sub>4</sub> Receptor Mediates Angiotensin II–Induced (Pro)Renin Receptor Expression in the Rat Renal Medulla
Hypertension 2014cited by 72position: middledoi
Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells
Cancer Letters 2013cited by 149position: lastdoi
Synthesis and Biological Evaluation of Novel Folic Acid Receptor-Targeted, β-Cyclodextrin-Based Drug Complexes for Cancer Treatment
PLoS ONE 2013cited by 61position: lastdoi
Nitro-oleic acid protects against adriamycin-induced nephropathy in mice
American Journal of Physiology-Renal Physiology 2013cited by 47position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zhi-Wei Zhou · Guiyang Medical University6 papers (2013–2016)Tianxin Yang · Tianjin University6 papers (2013–2016)Tianxin Yang · University of Utah5 papers (2013–2016)Wei Duan · Chongqing Technology and Business University5 papers (2013–2016)Xueji Zhang · Qingdao University5 papers (2013–2016)Zhi-Xu He · University of Kentucky5 papers (2013–2016)Xiaohan Lu · Nanjing University of Chinese Medicine4 papers (2014–2016)Fei Wang · Cornell University4 papers (2014–2016)Jia-Xuan Qiu · Nanchang University3 papers (2013–2016)Kexin Peng · Union Hospital3 papers (2014–2016)Yinxue Yang · University of Kentucky2 papers (2013–2016)Yaomin Du · Guangdong Provincial People's Hospital2 papers (2013–2014)Aihua Zhang · Model Animal Research Center2 papers (2013–2014)Shu-Ting Pan · Nanchang University2 papers (2014–2016)K.U. Chow · University of South Florida2 papers (2013–2015)Yumei Feng · Tulane University2 papers (2015–2016) · 1 papers (2013–2013)Chen-Zhong Li · Chinese University of Hong Kong1 papers (2013–2013)Kevin Yang · Northeastern University1 papers (2016–2016) · 1 papers (2013–2013)